Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Baxter
Merck
Dow
Mallinckrodt

Last Updated: May 29, 2023

Ortho Mcneil Pharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for ORTHO MCNEIL PHARM, and what generic and branded alternatives to ORTHO MCNEIL PHARM drugs are available?

ORTHO MCNEIL PHARM has twenty-nine approved drugs.



Summary for Ortho Mcneil Pharm
US Patents:0
Tradenames:32
Ingredients:17
NDAs:29

Drugs and US Patents for Ortho Mcneil Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm SALPIX acetrizoate sodium SOLUTION;INTRAUTERINE 009008-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Ortho Mcneil Pharm ORTHO-NOVUM 7/14-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 019004-002 Apr 4, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Ortho Mcneil Pharm FLOXIN ofloxacin INJECTABLE;INJECTION 020087-002 Mar 31, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Ortho Mcneil Pharm TYLENOL W/ CODEINE NO. 3 acetaminophen; codeine phosphate CAPSULE;ORAL 087422-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Ortho Mcneil Pharm ORTHO-NOVUM 1/80 28 mestranol; norethindrone TABLET;ORAL-28 016715-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Ortho Mcneil Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil Pharm FLOXIN IN DEXTROSE 5% ofloxacin INJECTABLE;INJECTION 020087-001 Mar 31, 1992 4,382,892 ⤷  Try a Trial
Ortho Mcneil Pharm FLOXIN ofloxacin INJECTABLE;INJECTION 020087-002 Mar 31, 1992 4,382,892 ⤷  Try a Trial
Ortho Mcneil Pharm FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER ofloxacin INJECTABLE;INJECTION 020087-004 Mar 31, 1992 4,382,892 ⤷  Try a Trial
Ortho Mcneil Pharm FLOXIN ofloxacin INJECTABLE;INJECTION 020087-003 Mar 31, 1992 4,382,892 ⤷  Try a Trial
Ortho Mcneil Pharm FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER ofloxacin INJECTABLE;INJECTION 020087-005 Mar 31, 1992 4,382,892 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Harvard Business School
Merck
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.